Bajaj Healthcare appoints Dr Mohammed Jaweed Mukarram as advisor in RnD division, specializing in APIs

Published On 2023-09-14 07:00 GMT   |   Update On 2023-09-14 07:00 GMT
Advertisement

Thane: Bajaj Healthcare Limited, a manufacturer of APIs, Intermediates and Formulations, has announced the appointment of Dr. Mohammed Jaweed Mukarram as an Advisor in the Research and Development division, specializing in Active Pharmaceutical Ingredients (APIs). He holds 45 years of Research Experience (including Ph.D as well as of post Doctoral).

Commenting on the above business update, Mr. Anil Jain, Joint Managing Director, Bajaj Healthcare said: “I am delighted to inform you that the Company has appointed Dr. Mohammed Jaweed Mukarram as an Advisor in the Research and Development division, specializing in Active Pharmaceutical Ingredients (APIs). Dr. Mohammed Jaweed Mukarram brings with him a wealth of experience spanning an impressive 45 years in the field of Research and Development (including Ph.D as well as of post Doctoral). His extensive knowledge and expertise make him a valuable addition to our team. Dr. Mohammed Jaweed Mukarram, holds both a Ph.D. and a post-Doctoral degree, underscoring his deep academic background and his commitment to advancing the field.
Advertisement
"With his remarkable credentials, we are confident that he will play a pivotal role in driving our research initiatives forward. Dr. Mohammed Jaweed Mukarram, illustrious career includes significant roles at esteemed organizations, such as Sr. Associate Director at Wockhardt, where he spearheaded the Chemical Research Division. Over the years, he has made a mark in the industry by filing a noteworthy 156 patent applications. His expertise has led to the successful handling of over 70 bulk drugs and intermediates, boasting an impressive 35 US Drug Master File (DMF) filings to date.” he added.

Bajaj Healthcare Limited, a manufacturer of APIs, Intermediates and Formulations, was established in the year 1993. It specializes in manufacturing of Intermediates, API, formulations & Nutraceuticals. The company has state-of-art manufacturing facilities, dedicated to APIs, Intermediates and formulation. The Company has a strong presence globally in countries like Europe, USA, Australia, Africa, Middle East and South America.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News